Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Housebuilders Hit By No-Deal Brexit Warning

Fri, 14th Sep 2018 10:32

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------Shire, up 1.8%. Takeda Pharmaceutical said it had received regulatory clearance in China for its GBP46 billion acquisition of the Irish drugmaker. The Japanese firm received unconditional approval for the deal announced in May from the State Administration for Market Regulation in China in what it termed "another key step" in the transaction process. Chinese approval follows progress with other global regulators. In July, the deal received the green light from the US Federal Trade Commission. It has also received unconditional approval from the Brazilian Administrative Council for Economic Defense. Under the deal, Takeda will pay USD30.33 in cash and 0.839 in new Takeda shares for each Shire share. This values the deal at around 4,990 pence per Shire share based on current prices and exchange rates.----------Whitbread, up 0.9%. The Costa Coffee shop and Premier Inn hotel chain owner was raised to Overweight from Neutral. ----------FTSE 100 - LOSERS----------Barratt Developments, down 1.2%, Taylor Wimpey, down 1.0%, Berkeley Group, down 0.2%, Persimmon, down 0.2%. London's large cap housebuilders were under selling pressure after Bank of England Governor Mark Carney warned UK ministers that house prices could crash by more than a third in the event of a chaotic, no-deal Brexit. Carney briefed Theresa May and senior ministers on the Bank's planning for a "cliff-edge" break with the EU at a special Cabinet meeting on Thursday to review the government's no-deal preparations. It is understood he warned house prices could fall by up to 35% over three years in a worst-case scenario, as sterling plummeted and the Bank was forced to push up interest rates. According to reports, he compared the fall-out from such a disorderly departure to the 2008 global financial crash. Ministers were said to have listened in silence as he and Chancellor Philip Hammond spelled out the grim consequences for the economy. His bleak prognosis came as France said it could halt flights and Eurostar trains from the UK if there was no agreement when the UK leaves the EU in March 2019.----------FTSE 250 - WINNERS----------Investec, up 11%. The Anglo-South African financial services firm said its interim profit is expected to be ahead of last year, as it also announced plans to demerge and publicly list its Asset Management unit. Following the conclusion of a strategic review, the company said that there are "compelling" linkages between its Specialist Banking and Wealth & Investment business. However, there are "limited synergies" between both of these divisions and Investec Asset Management. Therefore, the board has decided to demerge and publicly list the asset management unit. Separately, Investec said although its first half saw "macro challenges" in both South Africa and the UK, operating profit for the period is expected to be above last year.----------Close Brothers, up 2.1%. The merchant bank said it sold its retail finance business to Swedish firm Klarna Bank. The company said the disposal was prompted by its desire to exit the unsecured retail finance market. After assessing the market for a number of years, Close Brothers concluded that the unsecured nature of business activity was not a "long-term fit" for its otherwise secured business model. The retail finance unit, which provides unsecured loans to customers, had a loan book of GBP66.0 million as of July 31 this year. Close Brothers said the business will be treated as a discontinued operation in the full-year results to be released September 25. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Anglo African Agriculture, up 18% at 0.59 pence. The agriculture-focused investment company said it has received enough funding to finance a loan for a strategic logistics port in Kenya. Around GBP1.1 million was raised through a subscription raising GBP805,000 by issuing 161.0 million shares at 0.5 pence per share, and the issue of GBP250,000 of convertible loan notes, with a conversion price of 0.75p. The holder of the loan notes will be paid an annual interest rate of 12% in cash within a term of 24 months. If all loan notes are converted, 33.3 million shares would be issued, reflecting 7.9% of the company issued share capital.----------Character Group, up 9.3%. The toy designer and distributor said it expects its full-year results to "comfortably reach" market expectations after a good second half of the year. For the year ended August, a "very solid" performance was delivered by the firm as it continued to make "good progress in meeting the demands of our customers and the consumer". Character explained it had returned to its "previous growth pattern" in the second half of the year, as expected. Its UK domestic business, in particular, saw sales hit record highs. The company added that it "remains confident" in its "ability to grow the business profitably and expand its presence both domestically and internationally in the years to come".----------OTHER MAIN MARKET AND AIM - LOSERS----------Image Scan Holdings, down 15%. The x-ray screening systems maker said it expects to make a full-year loss and that it will now focus on organic growth instead of acquisitions following the failure of an earlier attempt. For the year ending September, the firm expects to see the number of industrial X-ray inspection system units sold to hit a record high. This was after the second half of the year saw the "strong sales" seen in the first half continue. During the year, its two largest industrial customers both bought new units for deployment into their global catalytic converter manufacturing operations. Image Scan added that "valuable" support contracts had also been put in place for these new units. Portable X-ray systems sales, however, had been "slower than hoped" in the second half. ----------Pan African Resources, down 9.7%. The miner said its annual earnings are set to drop amid an "incredibly challenging" operational environment. For the year ended June 30, headline earnings per share from continuing operations in ZAR terms is expected to be 47% to 57% lower than last year, between a range of 16.77 cents to 20.65 cents. For combined operations in rand terms, headline earnings per share is expected to be between 32% to 42% lower than last year in a range of 11.65 cents to 13.67 cents. In sterling terms, headline earnings per share from continuing operations is expected between 46% and 56% lower than last year in a range between 0.97 pence to 1.20p.----------
More News
14 Sep 2018 09:15

Shire gains as takeover approved by China

(Sharecast News) - Japan's Takeda Pharmaceutical has received regulatory approval from China for its $62bn takeover of London-listed Shire.

Read more
13 Sep 2018 10:56

Takada eyeing potential Shire asset sales to pay down debt

(Sharecast News) - Takeda Pharmaceutical may try and sell Shire's dry-eye drug once it completes the $62bn takeover purchase of the UK-listed biotech, according to a report on Thursday.

Read more
13 Sep 2018 08:25

Takeda weighs sale of Shire's eye care business to cut debt- Bloomberg

Sept 13 (Reuters) - Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks a

Read more
12 Sep 2018 16:12

Takeda to pack up Illinois HQ, nearly 1,000 workers to be affected

Sept 12 (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Wednesday it plans to shut its U.S. headquarters in Deerfield, Illinois and move it to the greater Boston area, following the —

Read more
12 Sep 2018 07:22

Shire gets EC marketing authorisation for 'VEYVONDI' treatment

(Sharecast News) - Rare diseases specialist Shire announced on Wednesday that the European Commission has granted marketing authorisation for 'VEYVONDI', for the treatment of bleeding events and the treatment and prevention of surgical bleeding in adults with von Willebrand disease, when desmopressin treatment alone is ineffective or not indicated.

Read more
10 Sep 2018 16:08

Two Shire Subsidiaries Receive Majority Early Offers For Senior Notes

LONDON (Alliance News) - Biotechnology company Shire PLC on Monday said two of its subsidiaries, Baxalta Inc and Shire Acquisitions Investments Ireland DAC, had received early offers for a of the

Read more
7 Sep 2018 09:33

BROKER RATINGS SUMMARY: Goldman Cuts Burberry; Redburn Cuts HSBC

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:----------FTSE 100----------GOLDMAN CUTS GROUP TO BUY -

Read more
6 Sep 2018 11:20

European Shares Reverse Early Losses On Improving Sentiment

BRUSSELS/FRANKFURT/PARIS (Alliance News) - European stocks were marginally higher on Thursday after having fallen to a five-month low earlier in the day.Sentiment improved somewhat after US

Read more
6 Sep 2018 10:54

TOP NEWS: Shire Buys Swiss Plasma Collection Firm Sanaplasma

LONDON (Alliance News) - Shire PLC said Thursday it has bought Swiss source plasma collection company sanaplasma AG for an undisclosed sum.The FTSE 100 pharmaceutical giant said that the is

Read more
6 Sep 2018 10:52

Shire buys Swiss plasma firm sanaplasma for undisclosed sum

(Sharecast News) - Pharmaceuticals giant Shire on Thursday said it had bought Switzerland's sanaplasma AG for an undisclosed sum.

Read more
6 Sep 2018 07:48

UPDATE 1-UK Stocks-Factors to watch on Sept. 6

Sept 6 (Reuters) - Britain's FTSE 100 futures were down 0.1 percent ahead of the cash market open on Thursday. * DIXONS CARPHONE: Dixons Carphone, the troubled British electricals and a

Read more
31 Aug 2018 10:16

Shire Completes USD2.4 Billion Oncology Franchise Sale To Servier

LONDON (Alliance News) - Irish biotechnology giant Shire PLC said Friday it has completed the sale of its oncology franchise to Servier SAS.The FTSE 100-listed company sold its franchise, a

Read more
31 Aug 2018 09:07

Shire completes $2.4bn oncology sale to Servier

(Sharecast News) - Shire has completed the sale of its oncology franchise to Servier for $2.4bn, it announced on Friday.

Read more
24 Aug 2018 14:04

TOP NEWS: Shire Launches Tender Offer To Buy Up To USD2 Billion Notes (ALLISS)

LONDON (Alliance News) - Biotechnology company Shire PLC on Friday said its wholly-owned subsidiaries Baxalta and Shire Acquisitions Investments Ireland DAC launched a tender offer to repurchase a

Read more
24 Aug 2018 13:54

MARKET ANALYSIS: Futures Pointing To Initial Strength On Wall Street

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Friday, with stocks likely to move to the upside after ending the previous session modestly upward on a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.